首页 > 最新文献

Vascular and Endovascular Surgery最新文献

英文 中文
Intra-Sac Injection of Thrombin During Endovascular Aneurysm Repair to Remedy Type II Endoleak and Promote Sac Shrinkage. 在血管内动脉瘤修补术中进行瘤窦内注射凝血酶,以修复 II 型内膜渗漏并促进瘤窦收缩。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-22 DOI: 10.1177/15385744231197457
Shi Lu Zhao, Jian Ping Xiong, Jing Yuan Luan, Zi Chang Jia, Jin Tao Han, Qi Chen Feng, Jin Man Zhuang, Tian Run Li, Chang Ming Wang, Xuan Li

Purpose: To evaluate the safety and effectiveness of intra-sac thrombin injection to remedy type II endoleaks (T2ELs) during endovascular aneurysm repair (EVAR).

Materials and methods: 224 cases abdominal aortic aneurysm (AAA) were treated with EVAR. For the 52 cases of intra-operative type II endoleaks and 8 cases of ruptured AAAs, after the grafts were deployed, thrombin was injected into the aneurysm sac through a preset catheter. The occurrence of endoleaks post-EVAR were followed up with by Computed Tomography (CT) angiogram. The diameter and the volume of the aneurysm sac were also measured. Endpoints included incidence of T2ELs, AAA sac shrinkage and re-intervention rate and all-cause mortality.

Results: The overall technical success rate was 100%. Fifty-two patients were followed up with for 9-56 (median 24) months. No serious complications were observed during follow-up. The incidence of endoleak was 5.8% (3/52) during follow-up. The maximum diameter of the aneurysm decreased from 61.1 ± 14.2 mm to 53.7 ± 10.6 mm, 47.9 ± 8.3 mm and 43.7 ± 7.2 mm (87.9%, 78.4% and 71.5% of pre-EVAR) at the 6-month, 1-year and 2-year follow-up, respectively (P < .05). The volume of the aneurysm sac shrank from 236.2 ± 136.2 cm3 to 202.6 ± 114.1 cm3, 155.6 ± 68.4 cm3 and 129.7 ± 52.4 cm3 (85.8%, 65.9%, and 54.9% of pre-EVAR) at the 6-month, 1-year and 2-year follow-up, respectively (P < .05). The rate of various endoleaks was 5.8% (3/52) and the re-intervention rate was 1.9% (1/52) in this research.

Conclusions: Clinical outcomes show that intra-sac injection of thrombin during EVAR is safe and may be effective in remedying small amount and low-velocity endoleaks and promoting shrinkage of the aneurysm sac.

目的:评估在血管内动脉瘤修补术(EVAR)中通过囊内注射凝血酶治疗II型内漏(T2ELs)的安全性和有效性。材料和方法:224例腹主动脉瘤(AAA)接受了EVAR治疗。对于 52 例术中 II 型内漏和 8 例破裂的 AAA,在移植物展开后,通过预设导管向动脉瘤囊注入凝血酶。通过计算机断层扫描(CT)血管造影对 EVAR 术后内漏的发生情况进行跟踪。同时还测量了动脉瘤囊的直径和体积。终点包括 T2EL 的发生率、AAA 囊的缩小、再次介入率和全因死亡率:结果:总体技术成功率为 100%。52名患者接受了9-56个月(中位24个月)的随访。随访期间未发现严重并发症。随访期间内漏发生率为 5.8%(3/52)。在 6 个月、1 年和 2 年的随访中,动脉瘤的最大直径分别从 61.1 ± 14.2 mm 降至 53.7 ± 10.6 mm、47.9 ± 8.3 mm 和 43.7 ± 7.2 mm(分别为 EVAR 术前的 87.9%、78.4% 和 71.5%)(P < .05)。在 6 个月、1 年和 2 年的随访中,动脉瘤囊的体积分别从 236.2 ± 136.2 立方厘米缩小到 202.6 ± 114.1 立方厘米、155.6 ± 68.4 立方厘米和 129.7 ± 52.4 立方厘米(分别为 EVAR 前的 85.8%、65.9% 和 54.9%)(P < .05)。本研究中各种内漏的发生率为 5.8%(3/52),再次介入率为 1.9%(1/52):临床结果表明,在 EVAR 过程中进行瘤囊内注射凝血酶是安全的,并能有效补救少量和低速内漏,促进动脉瘤瘤囊缩小。
{"title":"Intra-Sac Injection of Thrombin During Endovascular Aneurysm Repair to Remedy Type II Endoleak and Promote Sac Shrinkage.","authors":"Shi Lu Zhao, Jian Ping Xiong, Jing Yuan Luan, Zi Chang Jia, Jin Tao Han, Qi Chen Feng, Jin Man Zhuang, Tian Run Li, Chang Ming Wang, Xuan Li","doi":"10.1177/15385744231197457","DOIUrl":"10.1177/15385744231197457","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and effectiveness of intra-sac thrombin injection to remedy type II endoleaks (T2ELs) during endovascular aneurysm repair (EVAR).</p><p><strong>Materials and methods: </strong>224 cases abdominal aortic aneurysm (AAA) were treated with EVAR. For the 52 cases of intra-operative type II endoleaks and 8 cases of ruptured AAAs, after the grafts were deployed, thrombin was injected into the aneurysm sac through a preset catheter. The occurrence of endoleaks post-EVAR were followed up with by Computed Tomography (CT) angiogram. The diameter and the volume of the aneurysm sac were also measured. Endpoints included incidence of T2ELs, AAA sac shrinkage and re-intervention rate and all-cause mortality.</p><p><strong>Results: </strong>The overall technical success rate was 100%. Fifty-two patients were followed up with for 9-56 (median 24) months. No serious complications were observed during follow-up. The incidence of endoleak was 5.8% (3/52) during follow-up. The maximum diameter of the aneurysm decreased from 61.1 ± 14.2 mm to 53.7 ± 10.6 mm, 47.9 ± 8.3 mm and 43.7 ± 7.2 mm (87.9%, 78.4% and 71.5% of pre-EVAR) at the 6-month, 1-year and 2-year follow-up, respectively (<i>P</i> < .05). The volume of the aneurysm sac shrank from 236.2 ± 136.2 cm<sup>3</sup> to 202.6 ± 114.1 cm<sup>3</sup>, 155.6 ± 68.4 cm<sup>3</sup> and 129.7 ± 52.4 cm<sup>3</sup> (85.8%, 65.9%, and 54.9% of pre-EVAR) at the 6-month, 1-year and 2-year follow-up, respectively (<i>P</i> < .05). The rate of various endoleaks was 5.8% (3/52) and the re-intervention rate was 1.9% (1/52) in this research.</p><p><strong>Conclusions: </strong>Clinical outcomes show that intra-sac injection of thrombin during EVAR is safe and may be effective in remedying small amount and low-velocity endoleaks and promoting shrinkage of the aneurysm sac.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10048207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Iliac Branch Endoprosthesis to Rescue Inadvertent False Lumen Deployment of the Innominate Branch Stent During Physician-Modified Fenestrated-Branched Aortic Arch Repair. 使用髂支内膜修复在医生改良的主动脉弓修补术中因不慎造成的因诺门支支架假腔部署。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-07-20 DOI: 10.1177/15385744231191216
Sukgu M Han, Alexander D DiBartolomeo, Alyssa J Pyun, Shelley Maithel, Sanjeet Patel, Fernando Fleischman

A 70-year-old male with a history of 3 prior median sternotomies and on anticoagulation presented with acute chest and back pain associated with a pseudoaneurysm of the ascending and aortic arch in the setting of residual dissection involving the innominate, proximal right carotid, and subclavian arteries. A physician-modified triple vessel fenestrated-branched arch endograft was deployed. The innominate branch stent was deployed from the right carotid cut down, while the left carotid and left subclavian branch stents were placed from a femoral approach. Postoperatively, the innominate branch was found to be deployed in the false lumen of the dissected native innominate artery, leading to continued pressurization of the pseudoaneurysm. This was rescued by placing a Gore Iliac Branch Endoprosthesis (IBE) into the innominate branch through a temporary conduit sewn to the right carotid artery with a right subclavian branch placed via a brachial artery cut down into the internal iliac gate. The use of IBE allowed branch stent extension past the dissected native vessels. The patient had an uneventful recovery without neurologic complications. At 3-month follow-up, the patient remains well with an excluded pseudoaneurysm, and patent bifurcated innominate, bilateral carotid, and subclavian artery branches. A Gore IBE can be utilized in a dissected innominate artery to create an innominate branch device during fenestrated-branched endovascular arch repair.

一名 70 岁的男性患者曾接受过 3 次胸骨正中切开术,并服用了抗凝药,在腹股沟动脉、右颈动脉近端和锁骨下动脉残余夹层的情况下,出现急性胸痛和背痛,并伴有升主动脉弓假性动脉瘤。手术使用了医生改良的三血管栅栏式分支弓内膜移植。从右颈动脉切口向下植入主动脉分支支架,从股动脉切口植入左颈动脉和左锁骨下动脉分支支架。术后发现,贲门支支架被放置在断裂的原生贲门动脉假腔内,导致假性动脉瘤持续受压。通过与右颈动脉缝合的临时导管将戈尔髂支内膜假体(IBE)置入髂内支,并通过肱动脉切口将右锁骨下支置入髂内门,从而挽救了髂内支。IBE 的使用使得分支支架可以延伸到剥离的原生血管。患者恢复顺利,未出现神经系统并发症。在 3 个月的随访中,患者的情况依然良好,假性动脉瘤已排除,分叉的髂内、双侧颈动脉和锁骨下动脉分支通畅。戈尔 IBE 可用于剥离的髂内动脉,在血管内膜支架修复术中创建髂内动脉分支装置。
{"title":"Use of Iliac Branch Endoprosthesis to Rescue Inadvertent False Lumen Deployment of the Innominate Branch Stent During Physician-Modified Fenestrated-Branched Aortic Arch Repair.","authors":"Sukgu M Han, Alexander D DiBartolomeo, Alyssa J Pyun, Shelley Maithel, Sanjeet Patel, Fernando Fleischman","doi":"10.1177/15385744231191216","DOIUrl":"10.1177/15385744231191216","url":null,"abstract":"<p><p>A 70-year-old male with a history of 3 prior median sternotomies and on anticoagulation presented with acute chest and back pain associated with a pseudoaneurysm of the ascending and aortic arch in the setting of residual dissection involving the innominate, proximal right carotid, and subclavian arteries. A physician-modified triple vessel fenestrated-branched arch endograft was deployed. The innominate branch stent was deployed from the right carotid cut down, while the left carotid and left subclavian branch stents were placed from a femoral approach. Postoperatively, the innominate branch was found to be deployed in the false lumen of the dissected native innominate artery, leading to continued pressurization of the pseudoaneurysm. This was rescued by placing a Gore Iliac Branch Endoprosthesis (IBE) into the innominate branch through a temporary conduit sewn to the right carotid artery with a right subclavian branch placed via a brachial artery cut down into the internal iliac gate. The use of IBE allowed branch stent extension past the dissected native vessels. The patient had an uneventful recovery without neurologic complications. At 3-month follow-up, the patient remains well with an excluded pseudoaneurysm, and patent bifurcated innominate, bilateral carotid, and subclavian artery branches. A Gore IBE can be utilized in a dissected innominate artery to create an innominate branch device during fenestrated-branched endovascular arch repair.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9848908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Focal Renal Fibromuscular Dysplasia Treated With Angioplasty: A Case Report. 用血管成形术治疗局灶性肾纤维肌发育不良的罕见病例:病例报告
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-16 DOI: 10.1177/15385744231196627
Abdulqader Al-Falahi, Ghamdan Al-Aghbari, Maher Al-Muriesh

Background: Fibromuscular dysplasia is an idiopathic, segmental, nonatherosclerotic, noninflammatory vascular disease that can lead to arterial stenosis, tortuosity, occlusion, aneurysms, and dissection. Fibromuscular dysplasia is a rare cause of hypertension that can easily be missed. To date, there has been no definitive treatment for fibromuscular dysplasia.

Case report: In this report, we present an uncommon case of renovascular hypertension in a 21-year-old non-white female with a 3-year history of hypertension secondary to fibromuscular dysplasia involving bilateral renal arteries. Computed tomography angiography during the arterial phase revealed distal focal narrowing of the right main renal artery, distal focal narrowing of the left main renal artery, and proximal focal narrowing of the left accessory lower renal artery. Percutaneous balloon dilatation of the stenotic lesion was performed successfully up to 1 year After the procedure, the arterial blood pressure was within the normal range (110/70 to 125/75 mmHg) without medication. After 1 year of follow-up, CTA revealed re-stenosis in left main renal artery without clinical symptoms and normal blood pressure. Repeated procedure was done successfully.

Conclusions: This case report highlights the difficulty in the diagnosis and treatment of focal fibromuscular dysplasia in young non-white female patients. Computerized tomographic angiography is a useful tool for identifying the cause and showing the benefit of percutaneous transluminal renal angioplasty treatment for this rare entity, as an early percutaneous angioplasty intervention may have a clinical cure for hypertension.

背景:纤维肌发育不良是一种特发性、节段性、非动脉粥样硬化性、非炎症性血管疾病,可导致动脉狭窄、迂曲、闭塞、动脉瘤和夹层。纤维肌发育不良是一种罕见的高血压病因,很容易被漏诊。迄今为止,纤维肌发育不良还没有明确的治疗方法:在本报告中,我们介绍了一例罕见的新血管性高血压病例,患者是一名 21 岁的非白人女性,有 3 年高血压病史,继发于双侧肾动脉纤维肌性发育不良。动脉期计算机断层扫描血管造影显示,右主肾动脉远端灶性狭窄,左主肾动脉远端灶性狭窄,左侧附属下肾动脉近端灶性狭窄。经皮球囊扩张狭窄病变成功,术后一年动脉血压在正常范围内(110/70 至 125/75 mmHg),无需服药。随访 1 年后,CTA 显示左肾动脉主干再次狭窄,但无临床症状,血压正常。再次手术获得成功:本病例报告凸显了非白人年轻女性患者局灶性纤维肌性发育不良的诊断和治疗难度。计算机断层扫描血管造影术是确定病因的有用工具,并显示了经皮肾血管成形术治疗这种罕见病症的益处,因为早期经皮血管成形术干预可能会临床治愈高血压。
{"title":"A Rare Case of Focal Renal Fibromuscular Dysplasia Treated With Angioplasty: A Case Report.","authors":"Abdulqader Al-Falahi, Ghamdan Al-Aghbari, Maher Al-Muriesh","doi":"10.1177/15385744231196627","DOIUrl":"10.1177/15385744231196627","url":null,"abstract":"<p><strong>Background: </strong>Fibromuscular dysplasia is an idiopathic, segmental, nonatherosclerotic, noninflammatory vascular disease that can lead to arterial stenosis, tortuosity, occlusion, aneurysms, and dissection. Fibromuscular dysplasia is a rare cause of hypertension that can easily be missed. To date, there has been no definitive treatment for fibromuscular dysplasia.</p><p><strong>Case report: </strong>In this report, we present an uncommon case of renovascular hypertension in a 21-year-old non-white female with a 3-year history of hypertension secondary to fibromuscular dysplasia involving bilateral renal arteries. Computed tomography angiography during the arterial phase revealed distal focal narrowing of the right main renal artery, distal focal narrowing of the left main renal artery, and proximal focal narrowing of the left accessory lower renal artery. Percutaneous balloon dilatation of the stenotic lesion was performed successfully up to 1 year After the procedure, the arterial blood pressure was within the normal range (110/70 to 125/75 mmHg) without medication. After 1 year of follow-up, CTA revealed re-stenosis in left main renal artery without clinical symptoms and normal blood pressure. Repeated procedure was done successfully.</p><p><strong>Conclusions: </strong>This case report highlights the difficulty in the diagnosis and treatment of focal fibromuscular dysplasia in young non-white female patients. Computerized tomographic angiography is a useful tool for identifying the cause and showing the benefit of percutaneous transluminal renal angioplasty treatment for this rare entity, as an early percutaneous angioplasty intervention may have a clinical cure for hypertension.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10014562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Modern Series of Secondary Aortoenteric Fistula - A 19-Year Experience. 继发性肠瘘的现代系列治疗--19 年的经验。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-23 DOI: 10.1177/15385744231198363
Sabine Sieber, Albert Busch, Mine Sargut, Christoph Knappich, Bianca Bohmann, Angelos Karlas, Helmut Friess, Hans-Henning Eckstein, Alexander Novotny

Objectives: Secondary aortoenteric fistula is a rare and life-threatening condition. Clear evidence on the ideal therapeutic approach is largely missing. This study aims to analyze symptoms, etiology, risk factors, and outcomes based on procedural details.

Patients and methods: All patients with secondary aortoenteric fistula admitted between 2003 and 2021 were included. Patient characteristics, surgical procedure details, and postoperative outcomes were analyzed. Outcomes were stratified and compared according to the urgency of operation and the procedure performed. Descriptive statistics were used. The primary endpoint was in-hospital mortality.

Results: A total of twentytwo patients (68% male, median age 70 years) were identified. Main symptoms were gastrointestinal bleeding, pain, and fever. From the twentytwo patients ten patients required emergency surgery and ten urgent surgery. Emergency patients were older on average (74 vs 63 years, P = .015) and had a higher risk of postoperative respiratory complications (80% vs 10%, P = .005). Primary open surgery with direct replacement of the aorta or an extra-anatomic bypass with an additional direct suture or resection of the involved bowel was performed in sixteen patients. In four patients underwent endovascular bridging treatment with the definitive approach as a second step. Other two patients died without operation (1x refusal; 1x palliative cancer history). In-hospital mortality was 27%, respectively. Compared to patients undergoing urgent surgery, those treated emergently showed significantly higher in-hospital (50% vs 0%, P = .0033) mortalities.

Conclusion: Despite rapid diagnosis and treatment, secondary aortoenteric fistula remains a life-threatening condition with 27% in-hospital mortality, significantly increased upon emergency presentation.

目的:继发性肠主动脉瘘是一种罕见且危及生命的疾病。关于理想的治疗方法,目前还缺乏明确的证据。本研究旨在根据手术细节分析症状、病因、风险因素和预后:纳入2003年至2021年间收治的所有继发性肠主动脉瘘患者。分析了患者特征、手术过程细节和术后结果。根据手术的紧急程度和所实施的手术对结果进行分层和比较。采用了描述性统计方法。主要终点是院内死亡率:共确定了 22 名患者(68% 为男性,中位年龄为 70 岁)。主要症状为消化道出血、疼痛和发热。22 名患者中有 10 人需要进行急诊手术,10 人需要进行紧急手术。急诊患者平均年龄较大(74 岁对 63 岁,P = .015),术后出现呼吸系统并发症的风险较高(80% 对 10%,P = .005)。有 16 名患者接受了直接置换主动脉或解剖外搭桥的初级开放手术,并进行了额外的直接缝合或受累肠道切除术。四名患者接受了血管内桥接治疗,作为第二步的最终方法。另外两名患者在未进行手术的情况下死亡(1 人拒绝手术;1 人有姑息性癌症病史)。院内死亡率分别为27%。与接受紧急手术的患者相比,急诊患者的院内死亡率明显更高(50% vs 0%,P = .0033):结论:尽管诊断和治疗迅速,但继发性肠主动脉瘘仍是一种危及生命的疾病,院内死亡率为27%,急诊患者的院内死亡率明显升高。
{"title":"A Modern Series of Secondary Aortoenteric Fistula - A 19-Year Experience.","authors":"Sabine Sieber, Albert Busch, Mine Sargut, Christoph Knappich, Bianca Bohmann, Angelos Karlas, Helmut Friess, Hans-Henning Eckstein, Alexander Novotny","doi":"10.1177/15385744231198363","DOIUrl":"10.1177/15385744231198363","url":null,"abstract":"<p><strong>Objectives: </strong>Secondary aortoenteric fistula is a rare and life-threatening condition. Clear evidence on the ideal therapeutic approach is largely missing. This study aims to analyze symptoms, etiology, risk factors, and outcomes based on procedural details.</p><p><strong>Patients and methods: </strong>All patients with secondary aortoenteric fistula admitted between 2003 and 2021 were included. Patient characteristics, surgical procedure details, and postoperative outcomes were analyzed. Outcomes were stratified and compared according to the urgency of operation and the procedure performed. Descriptive statistics were used. The primary endpoint was in-hospital mortality.</p><p><strong>Results: </strong>A total of twentytwo patients (68% male, median age 70 years) were identified. Main symptoms were gastrointestinal bleeding, pain, and fever. From the twentytwo patients ten patients required emergency surgery and ten urgent surgery. Emergency patients were older on average (74 vs 63 years, <i>P</i> = .015) and had a higher risk of postoperative respiratory complications (80% vs 10%, <i>P</i> = .005). Primary open surgery with direct replacement of the aorta or an extra-anatomic bypass with an additional direct suture or resection of the involved bowel was performed in sixteen patients. In four patients underwent endovascular bridging treatment with the definitive approach as a second step. Other two patients died without operation (1x refusal; 1x palliative cancer history). In-hospital mortality was 27%, respectively. Compared to patients undergoing urgent surgery, those treated emergently showed significantly higher in-hospital (50% vs 0%, <i>P</i> = .0033) mortalities.</p><p><strong>Conclusion: </strong>Despite rapid diagnosis and treatment, secondary aortoenteric fistula remains a life-threatening condition with 27% in-hospital mortality, significantly increased upon emergency presentation.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10054221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreaticoduodenal Artery Aneurysm Complicated by Median Arcuate Ligament Syndrome. 胰十二指肠动脉瘤并发正中弓形韧带综合征
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-27 DOI: 10.1177/15385744231198934
Sean Hamlin, Stephen R Gallo, Jameson Petrochko, Jacob Wilson, Sharvil Sheth

Purpose: To highlight median arcuate ligament syndrome as a potential cause for celiac artery stenosis and pancreaticoduodenal artery aneurysm, and describe treatment options in this setting.

Case report: A 63-year-old male presented with a pancreaticoduodenal artery aneurysm and concomitant celiac artery stenosis that was treated with celiac artery stenting and aneurysm coiling. He subsequently developed stent fracture and celiac artery occlusion secondary to previously unrecognized median arcuate ligament syndrome causing reperfusion of the aneurysm. This was treated with open median arcuate ligament release and aorta to common hepatic artery bypass with good clinical result and stable 20-month surveillance imaging.

Conclusion: It is critical to recognize median arcuate ligament syndrome as a cause of celiac artery stenosis in the setting of pancreaticoduodenal artery aneurysm given the high risk of failure of endovascular stenting. Open aorto-hepatic artery bypass and endovascular aneurysm coiling should be the preferred approach in these patients.

目的:强调正中弓形韧带综合征是腹腔动脉狭窄和胰十二指肠动脉瘤的潜在病因,并描述这种情况下的治疗方案:一名 63 岁的男性患有胰十二指肠动脉瘤,同时伴有腹腔动脉狭窄,曾接受腹腔动脉支架和动脉瘤卷绕术治疗。随后,他出现了支架断裂和腹腔动脉闭塞,继发于之前未被发现的正中弓状韧带综合征,导致动脉瘤再灌注。经开放性弓状内韧带松解术和主动脉至肝总动脉搭桥术治疗后,临床效果良好,20 个月的监测造影结果稳定:结论:鉴于血管内支架治疗失败的风险很高,因此在胰十二指肠动脉瘤的情况下,将弓状韧带综合征视为腹腔动脉狭窄的病因至关重要。这些患者应首选开放式肝主动脉搭桥术和血管内动脉瘤夹闭术。
{"title":"Pancreaticoduodenal Artery Aneurysm Complicated by Median Arcuate Ligament Syndrome.","authors":"Sean Hamlin, Stephen R Gallo, Jameson Petrochko, Jacob Wilson, Sharvil Sheth","doi":"10.1177/15385744231198934","DOIUrl":"10.1177/15385744231198934","url":null,"abstract":"<p><strong>Purpose: </strong>To highlight median arcuate ligament syndrome as a potential cause for celiac artery stenosis and pancreaticoduodenal artery aneurysm, and describe treatment options in this setting.</p><p><strong>Case report: </strong>A 63-year-old male presented with a pancreaticoduodenal artery aneurysm and concomitant celiac artery stenosis that was treated with celiac artery stenting and aneurysm coiling. He subsequently developed stent fracture and celiac artery occlusion secondary to previously unrecognized median arcuate ligament syndrome causing reperfusion of the aneurysm. This was treated with open median arcuate ligament release and aorta to common hepatic artery bypass with good clinical result and stable 20-month surveillance imaging.</p><p><strong>Conclusion: </strong>It is critical to recognize median arcuate ligament syndrome as a cause of celiac artery stenosis in the setting of pancreaticoduodenal artery aneurysm given the high risk of failure of endovascular stenting. Open aorto-hepatic artery bypass and endovascular aneurysm coiling should be the preferred approach in these patients.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Type B Aortic Dissection Complicated With Spinal Cord Ischemia and Paraplegia Treated With Endovascular Scissor Technique. 用血管内剪刀技术治疗急性 B 型主动脉夹层并发脊髓缺血和截瘫。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-28 DOI: 10.1177/15385744231198715
Alexandra Catasta, Antonio Freyrie, Alberto Bramucci, Claudio Bianchini Massoni, Paolo Perini

Spinal cord ischemia leading to paraplegia is a rare, life-limiting complication of acute type B aortic dissection. We report a case of spinal cord ischemia occurred in a young woman treated with endovascular scissor technique in urgent setting. The patient had an uneventful post-procedural course. After 4 months, computed tomography angiography confirmed false lumen reperfusion and major symptoms were regressed. In selected cases, this procedure is a tool to improve false lumen perfusion in type B dissections, and demonstrated to be helpful in our case of spinal cord ischaemia.

脊髓缺血导致截瘫是急性 B 型主动脉夹层的一种罕见并危及生命的并发症。我们报告了一例在紧急情况下使用血管内剪刀技术治疗的年轻女性脊髓缺血病例。患者术后恢复顺利。4 个月后,计算机断层扫描血管造影证实了假腔再灌注,主要症状也得到缓解。在选定的病例中,这种手术是改善B型血管断裂假腔灌注的一种工具,在我们的脊髓缺血病例中也得到了证实。
{"title":"Acute Type B Aortic Dissection Complicated With Spinal Cord Ischemia and Paraplegia Treated With Endovascular Scissor Technique.","authors":"Alexandra Catasta, Antonio Freyrie, Alberto Bramucci, Claudio Bianchini Massoni, Paolo Perini","doi":"10.1177/15385744231198715","DOIUrl":"10.1177/15385744231198715","url":null,"abstract":"<p><p>Spinal cord ischemia leading to paraplegia is a rare, life-limiting complication of acute type B aortic dissection. We report a case of spinal cord ischemia occurred in a young woman treated with endovascular scissor technique in urgent setting. The patient had an uneventful post-procedural course. After 4 months, computed tomography angiography confirmed false lumen reperfusion and major symptoms were regressed. In selected cases, this procedure is a tool to improve false lumen perfusion in type B dissections, and demonstrated to be helpful in our case of spinal cord ischaemia.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10166603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revision Surgery is Possible in Patients With Previous Bovine Pericardium Inferior Vena Cava Reconstruction: A Case Series and Review of Literature. 曾接受过牛心包下腔静脉重建术的患者可以进行翻修手术:病例系列和文献综述。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-07-10 DOI: 10.1177/15385744231189021
Charles Risbey, Oleksandr Khoma, Joo-Shik Shin, Charbel Sandroussi

There is a paucity of research investigating revision surgery for patients with previous inferior vena cava (IVC) reconstruction using bovine pericardium (BP). To the best of our knowledge, no reports of redo procedures have been published in the medical literature. We describe two cases of redo surgery in patients with previous IVC reconstructions using BP following disease recurrence. The first case underwent resection of the BP graft with a second IVC reconstruction using BP, the second case underwent resection of the BP graft without reconstruction due to extensive thromboses. Neither case experienced perioperative complication or morbidity following their redo procedure, and previous IVC reconstruction with BP did not present significant intraoperative technical challenges. One case showed evidence of endothelialisation of the excised BP graft, however, it was not possible to definitively conclude if endothelialisation was present in the second case. Overall, these cases demonstrate that previous IVC reconstruction using BP should not be considered an absolute contraindication for redo surgery in the context of disease recurrence.

对于曾使用牛心包(BP)重建下腔静脉(IVC)的患者进行翻修手术的研究很少。据我们所知,医学文献中还没有关于重做手术的报道。我们介绍了两例曾使用 BP 重建 IVC 的患者在疾病复发后重新进行手术的病例。第一个病例切除了BP移植物,并使用BP进行了第二次IVC重建;第二个病例由于广泛血栓形成,切除了BP移植物,但没有进行重建。两例患者在重做手术后都没有出现围手术期并发症或发病率,之前使用 BP 重建的 IVC 在术中也没有遇到重大的技术挑战。一个病例显示切除的 BP 移植体有内皮化的迹象,但第二个病例无法明确断定是否存在内皮化。总之,这些病例表明,在疾病复发的情况下,先前使用 BP 重建 IVC 不应被视为重做手术的绝对禁忌症。
{"title":"Revision Surgery is Possible in Patients With Previous Bovine Pericardium Inferior Vena Cava Reconstruction: A Case Series and Review of Literature.","authors":"Charles Risbey, Oleksandr Khoma, Joo-Shik Shin, Charbel Sandroussi","doi":"10.1177/15385744231189021","DOIUrl":"10.1177/15385744231189021","url":null,"abstract":"<p><p>There is a paucity of research investigating revision surgery for patients with previous inferior vena cava (IVC) reconstruction using bovine pericardium (BP). To the best of our knowledge, no reports of redo procedures have been published in the medical literature. We describe two cases of redo surgery in patients with previous IVC reconstructions using BP following disease recurrence. The first case underwent resection of the BP graft with a second IVC reconstruction using BP, the second case underwent resection of the BP graft without reconstruction due to extensive thromboses. Neither case experienced perioperative complication or morbidity following their redo procedure, and previous IVC reconstruction with BP did not present significant intraoperative technical challenges. One case showed evidence of endothelialisation of the excised BP graft, however, it was not possible to definitively conclude if endothelialisation was present in the second case. Overall, these cases demonstrate that previous IVC reconstruction using BP should not be considered an absolute contraindication for redo surgery in the context of disease recurrence.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9923623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phantom Limb Pain and Painful Neuroma After Dysvascular Lower-Extremity Amputation: A Systematic Review and Meta-Analysis. 下肢血管错构瘤截肢后的幻肢痛和疼痛性神经瘤:系统回顾与元分析》。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-24 DOI: 10.1177/15385744231197097
Mirte Langeveld, Romy Bosman, Caroline A Hundepool, Liron S Duraku, Christopher McGhee, J Michiel Zuidam, Tom Barker, Maciej Juszczak, Dominic M Power

Background: Phantom limb pain (PLP) and symptomatic neuroma can be debilitating and significantly impact the quality of life of amputees. However, the prevalence of PLP and symptomatic neuromas in patients following dysvascular lower limb amputation (LLA) has not been reliably established. This systematic review and meta-analysis evaluates the prevalence and incidence of phantom limb pain and symptomatic neuroma after dysvascular LLA.

Methods: Four databases (Embase, MEDLINE, Cochrane Central, and Web of Science) were searched on October 5th, 2022. Prospective or retrospective observational cohort studies or cross-sectional studies reporting either the prevalence or incidence of phantom limb pain and/or symptomatic neuroma following dysvascular LLA were identified. Two reviewers independently conducted the screening, data extraction, and the risk of bias assessment according to the PRISMA guidelines. To estimate the prevalence of phantom limb pain, a meta-analysis using a random effects model was performed.

Results: Twelve articles were included in the quantitative analysis, including 1924 amputees. A meta-analysis demonstrated that 69% of patients after dysvascular LLA experience phantom limb pain (95% CI 53-86%). The reported pain intensity on a scale from 0-10 in LLA patients ranged between 2.3 ± 1.4 and 5.5 ± .7. A single study reported an incidence of symptomatic neuroma following dysvascular LLA of 5%.

Conclusions: This meta-analysis demonstrates the high prevalence of phantom limb pain after dysvascular LLA. Given the often prolonged and disabling nature of neuropathic pain and the difficulties managing it, more consideration needs to be given to strategies to prevent it at the time of amputation.

背景:幻肢痛(PLP)和症状性神经瘤会使人衰弱,严重影响截肢者的生活质量。然而,目前尚未可靠地确定血管性下肢截肢(LLA)患者中幻肢痛和症状性神经瘤的发病率。本系统综述和荟萃分析评估了血管性下肢截肢术后幻肢痛和症状性神经瘤的患病率和发生率:于2022年10月5日检索了四个数据库(Embase、MEDLINE、Cochrane Central和Web of Science)。方法:于2022年10月5日检索了四个数据库(EmbedLINE、MEDLINE、Cochrane Central、Web Science),其中包括前瞻性或回顾性观察性队列研究或横断面研究,这些研究均报告了血管性LLA术后幻肢痛和/或症状性神经肿的患病率或发生率。两名审稿人根据 PRISMA 指南独立进行筛选、数据提取和偏倚风险评估。为了估计幻肢痛的发生率,采用随机效应模型进行了荟萃分析:定量分析共纳入了 12 篇文章,包括 1924 名截肢者。荟萃分析表明,69%的血管性截肢术后患者会出现幻肢痛(95% CI 53-86%)。据报告,LLA 患者的疼痛强度(0-10 分)从 2.3 ± 1.4 到 5.5 ± .7 不等。一项研究报告称,血管发育不良 LLA 后症状性神经瘤的发生率为 5%:这项荟萃分析表明,血管下腔静脉置换术后幻肢痛的发生率很高。鉴于神经病理性疼痛通常持续时间较长、致残性较强,且难以控制,因此需要更多地考虑在截肢时采取预防策略。
{"title":"Phantom Limb Pain and Painful Neuroma After Dysvascular Lower-Extremity Amputation: A Systematic Review and Meta-Analysis.","authors":"Mirte Langeveld, Romy Bosman, Caroline A Hundepool, Liron S Duraku, Christopher McGhee, J Michiel Zuidam, Tom Barker, Maciej Juszczak, Dominic M Power","doi":"10.1177/15385744231197097","DOIUrl":"10.1177/15385744231197097","url":null,"abstract":"<p><strong>Background: </strong>Phantom limb pain (PLP) and symptomatic neuroma can be debilitating and significantly impact the quality of life of amputees. However, the prevalence of PLP and symptomatic neuromas in patients following dysvascular lower limb amputation (LLA) has not been reliably established. This systematic review and meta-analysis evaluates the prevalence and incidence of phantom limb pain and symptomatic neuroma after dysvascular LLA.</p><p><strong>Methods: </strong>Four databases (Embase, MEDLINE, Cochrane Central, and Web of Science) were searched on October 5<sup>th</sup>, 2022. Prospective or retrospective observational cohort studies or cross-sectional studies reporting either the prevalence or incidence of phantom limb pain and/or symptomatic neuroma following dysvascular LLA were identified. Two reviewers independently conducted the screening, data extraction, and the risk of bias assessment according to the PRISMA guidelines. To estimate the prevalence of phantom limb pain, a meta-analysis using a random effects model was performed.</p><p><strong>Results: </strong>Twelve articles were included in the quantitative analysis, including 1924 amputees. A meta-analysis demonstrated that 69% of patients after dysvascular LLA experience phantom limb pain (95% CI 53-86%). The reported pain intensity on a scale from 0-10 in LLA patients ranged between 2.3 ± 1.4 and 5.5 ± .7. A single study reported an incidence of symptomatic neuroma following dysvascular LLA of 5%.</p><p><strong>Conclusions: </strong>This meta-analysis demonstrates the high prevalence of phantom limb pain after dysvascular LLA. Given the often prolonged and disabling nature of neuropathic pain and the difficulties managing it, more consideration needs to be given to strategies to prevent it at the time of amputation.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10443139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multilayer Stent for Emergency Treatment of Acute Type B Aortic Dissection: A Case Report. 多层支架用于急性 B 型主动脉夹层的紧急治疗:病例报告
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-02 DOI: 10.1177/15385744231190448
Bernardo Kremer Diniz, Marcello Sena, Paulo Henrique Lima

Purpose: We report the case of an acute type B dissection with high-risk features treated with multilayer stent.

Case report: A 50-year-old female patient presented to the emergency department with an acute type B aortic dissection. Conservative medical treatment did control blood pressure but did not alleviate her dissection symptoms. She was treated endovascularly with multilayer stents extensively covering the whole dissected area. HThe aortic arch side branches, visceral arteries and renal arteries remained patent after treatment. The recovery was uneventful, and she was discharged the day after the intervention. At 6- and 12-month follow-up, the patient remained asymptomatic, the true lumen volume increased and all side branches remained patent.

Conclusion: We present a case of the use of a multilayer stent for acute type B aortic dissection. This technique allows to treat the whole dissection with low risk of paraplegia or side branch occlusion. Long-term results of ongoing clinical studies should confirm the place of the multilayer stent as a treatment option for type B aortic dissection.

目的:我们报告了一例使用多层支架治疗具有高风险特征的急性 B 型主动脉夹层的病例:一名 50 岁的女性患者因急性 B 型主动脉夹层来到急诊科就诊。保守治疗控制了血压,但并未缓解夹层症状。她接受了血管内治疗,多层支架广泛覆盖了整个夹层区域。治疗后,主动脉弓侧支、内脏动脉和肾动脉保持通畅。术后恢复顺利,术后第二天就出院了。在 6 个月和 12 个月的随访中,患者仍无症状,真腔容积增加,所有侧支保持通畅:我们介绍了一例使用多层支架治疗急性 B 型主动脉夹层的病例。结论:我们展示了一例使用多层支架治疗急性 B 型主动脉夹层的病例,这种技术可以治疗整个夹层,而且发生截瘫或侧枝闭塞的风险较低。正在进行的临床研究的长期结果将证实多层支架作为治疗 B 型主动脉夹层的一种选择。
{"title":"Multilayer Stent for Emergency Treatment of Acute Type B Aortic Dissection: A Case Report.","authors":"Bernardo Kremer Diniz, Marcello Sena, Paulo Henrique Lima","doi":"10.1177/15385744231190448","DOIUrl":"10.1177/15385744231190448","url":null,"abstract":"<p><strong>Purpose: </strong>We report the case of an acute type B dissection with high-risk features treated with multilayer stent.</p><p><strong>Case report: </strong>A 50-year-old female patient presented to the emergency department with an acute type B aortic dissection. Conservative medical treatment did control blood pressure but did not alleviate her dissection symptoms. She was treated endovascularly with multilayer stents extensively covering the whole dissected area. HThe aortic arch side branches, visceral arteries and renal arteries remained patent after treatment. The recovery was uneventful, and she was discharged the day after the intervention. At 6- and 12-month follow-up, the patient remained asymptomatic, the true lumen volume increased and all side branches remained patent.</p><p><strong>Conclusion: </strong>We present a case of the use of a multilayer stent for acute type B aortic dissection. This technique allows to treat the whole dissection with low risk of paraplegia or side branch occlusion. Long-term results of ongoing clinical studies should confirm the place of the multilayer stent as a treatment option for type B aortic dissection.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9911364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Value of Lower Extremity Venous Duplication via Digital Subtraction Angiography Guided Venography. 通过数字减影血管造影引导静脉造影诊断下肢静脉复制的价值。
IF 0.9 4区 医学 Q3 Medicine Pub Date : 2024-02-01 Epub Date: 2023-08-22 DOI: 10.1177/15385744231198355
Ming Tang, Weijian Fan, Jianwei Cui, Qingling Liu, Xindong Chang, Mingfei He, Qingqing Fang, Siyuan Wang, Mianpeng Chen, Shiwu Yin

Introduction: Lower limb venous anomalies, including duplicated veins, are common and have significant impacts on the outcomes and efficacy of venous surgery. Digital subtraction angiography (DSA) guided venography, serving as the tertiary diagnostic option for venous disorders, offers valuable informations to clinical practitioners.

Patients and methods: A retrospective study was conducted on 195 patients with suspected venous disease, evaluating 259 limbs with venography imaging. Two experienced interventional vascularists evaluated the images to determine the incidence and characteristics of variances in the femoral, popliteal, great saphenous, and small saphenous veins. Moreover, blood samples were collected to assess the safety of the venography procedure by monitoring changes in renal function.

Result: Duplication variations were found in the lower limb veins, with the highest prevalence in the femoral vein (11.28%, 22/195), followed by the great saphenous vein (4.1%, 8/195), and the popliteal vein (1.54%, 3/195). No severe contrast agent allergies or postoperative complications were reported. No statistically significant differences were found in creatinine and urea levels pre- and post-operation for patients without duplication variations, those with duplication of the great saphenous, femoral, or popliteal vein (P < .05).

Conclusion: DSA-guided venography is effective in identifying venous variations in lower limb disease. DFV is the most common recurrent vein, while DPV is the least. Adequate preparation ensures safety, high spatial resolution, dynamic imaging, and low tissue interference.

导言:下肢静脉异常(包括重复静脉)很常见,对静脉手术的结果和疗效有重大影响。数字减影血管造影术(DSA)引导下的静脉造影术作为静脉疾病的三级诊断选择,为临床医师提供了宝贵的信息:我们对 195 名疑似静脉疾病患者进行了回顾性研究,对 259 条肢体进行了静脉造影成像评估。两名经验丰富的介入血管专家对图像进行了评估,以确定股静脉、腘静脉、大隐静脉和小隐静脉变异的发生率和特征。此外,还采集了血液样本,通过监测肾功能的变化来评估静脉造影术的安全性:结果:在下肢静脉中发现了重复变异,其中股静脉的重复率最高(11.28%,22/195),其次是大隐静脉(4.1%,8/195)和腘静脉(1.54%,3/195)。没有严重造影剂过敏或术后并发症的报告。无重复变异、大隐静脉、股静脉或腘静脉重复的患者术前和术后的肌酐和尿素水平差异无统计学意义(P < .05):结论:DSA引导下的静脉造影能有效识别下肢疾病中的静脉变异。DFV是最常见的复发性静脉,而DPV则最少见。充分的准备可确保安全、高空间分辨率、动态成像和低组织干扰。
{"title":"Diagnostic Value of Lower Extremity Venous Duplication via Digital Subtraction Angiography Guided Venography.","authors":"Ming Tang, Weijian Fan, Jianwei Cui, Qingling Liu, Xindong Chang, Mingfei He, Qingqing Fang, Siyuan Wang, Mianpeng Chen, Shiwu Yin","doi":"10.1177/15385744231198355","DOIUrl":"10.1177/15385744231198355","url":null,"abstract":"<p><strong>Introduction: </strong>Lower limb venous anomalies, including duplicated veins, are common and have significant impacts on the outcomes and efficacy of venous surgery. Digital subtraction angiography (DSA) guided venography, serving as the tertiary diagnostic option for venous disorders, offers valuable informations to clinical practitioners.</p><p><strong>Patients and methods: </strong>A retrospective study was conducted on 195 patients with suspected venous disease, evaluating 259 limbs with venography imaging. Two experienced interventional vascularists evaluated the images to determine the incidence and characteristics of variances in the femoral, popliteal, great saphenous, and small saphenous veins. Moreover, blood samples were collected to assess the safety of the venography procedure by monitoring changes in renal function.</p><p><strong>Result: </strong>Duplication variations were found in the lower limb veins, with the highest prevalence in the femoral vein (11.28%, 22/195), followed by the great saphenous vein (4.1%, 8/195), and the popliteal vein (1.54%, 3/195). No severe contrast agent allergies or postoperative complications were reported. No statistically significant differences were found in creatinine and urea levels pre- and post-operation for patients without duplication variations, those with duplication of the great saphenous, femoral, or popliteal vein (<i>P</i> < .05).</p><p><strong>Conclusion: </strong>DSA-guided venography is effective in identifying venous variations in lower limb disease. DFV is the most common recurrent vein, while DPV is the least. Adequate preparation ensures safety, high spatial resolution, dynamic imaging, and low tissue interference.</p>","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10041919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Vascular and Endovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1